Home » FDA News »

Eurogentec’s Biologics Facility Successfully Completes US FDA Inspection – EON: Enhanced Online News (press release)

 

Eurogentec's Biologics Facility Successfully Completes US FDA Inspection
EON: Enhanced Online News (press release)
This FDA status allows Eurogentec to manufacture a commercial bulk parenteral biopharmaceutical for one of its clients for the US market. “We are very pleased with the status we have received from the FDA; this demonstrates our continued commitment to ...

and more »
 

Related Posts

  • No Related Posts
 
 

0 Comments

You can be the first one to leave a comment.

 
 

Leave a Comment

 




 
 
 
 
 
This site is protected by WP-CopyRightPro